Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioremTSXV:BRM +0.67%90 Market Cap is C$48.87 Mil as of Jul. 21, 2026. GuruFocus rates TSXV:BRM with a GF Score™ of 90/100 and a GF Value™ of C$2.77 (Fairly Valued). Among 3,096 Industrial Products companies, Biorem ranks worse than 78.59% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Biorem's share price for the quarter that ended in Mar. 2026 was C$2.46. Biorem's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 16.14 Mil. Therefore, Biorem's market cap for the quarter that ended in Mar. 2026 was C$39.69 Mil.
Biorem's quarterly market cap
increased
from Sep. 2025 (C$31.37 Mil) to Dec. 2025 (C$43.56 Mil) but then
declined
from Dec. 2025 (C$43.56 Mil) to Mar. 2026 (C$39.69 Mil).
Biorem's annual market cap
increased
from Dec. 2023 (C$15.70 Mil) to Dec. 2024 (C$49.22 Mil) but then
declined
from Dec. 2024 (C$49.22 Mil) to Dec. 2025 (C$43.56 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Biorem's Enterprise Value for Today is C$41.53 Mil.
Biorem (TSXV:BRM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Biorem Market Cap Related Terms
Biorem Market Cap Historical Data
* Premium members only.
The historical data trend for Biorem's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:BRM vs VLTO, ZWS, CECO: Market Cap Comparison
For the Pollution & Treatment Controls subindustry, Biorem's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biorem Market Cap vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Biorem's Market Cap distribution charts can be found below:
* The bar in red indicates where Biorem's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Biorem's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biorem (TSXV:BRM) has a Market Cap of C$48.87 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Biorem and its competitors. According to the industry distribution chart, Biorem ranks #2433 out of 3096 companies in the Industrial Products industry, placing it in the top 78.6%.
Is Biorem's Market Cap too high?
Biorem's current Market Cap is C$48.87 Mil. Based on the distribution chart, Biorem ranks #2433 out of 3096 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Biorem has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Biorem's Market Cap compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Biorem ranks #2433 out of 3096 companies for Market Cap. This places Biorem in the lower half of its industry. The industry median Market Cap is 258.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for an Industrial Products company?
The median Market Cap among Industrial Products companies is 258.26, based on 3,096 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Biorem and its competitors. For the Industrial Products industry, the median Market Cap is 258.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biorem's current Market Cap is C$48.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (TSXV:BRM) is currently considered Fairly Valued. The stock's GF Value™ is C$2.77, compared to a current price of C$3.01 — trading 8.7% above its estimated fair value. The current Market Cap is C$48.87 Mil. Biorem's overall GF Score™ is 90/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Biorem (TSXV:BRM), the current Market Cap is C$48.87 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biorem (TSXV:BRM) Overvalued in 2026?
Based on GuruFocus' analysis, Biorem stock appears to be overvalued.
The current stock price of C$3.01 is trading 8.7% above its estimated GF Value™ of C$2.77.
GuruFocus considers Biorem to be Fairly Valued.
Key valuation signals for TSXV:BRM:
Market Cap: C$48.87 Mil
GF Value™: C$2.77 vs. price of C$3.01 (8.7% above fair value)
No single metric tells the full story. See the TSXV:BRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
90GF Score
Get the complete analysis for TSXV:BRM
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:BRM has been successfully added to your 
